See All Slides - tctmd.com

Slides

Presentation TCT 2012

Pathogenesis of Vulnerable Plaque 2012: What's New?

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

Selection of Angioplasty Guiding Catheters, Wires, and Balloons

Presenter: Aaron Kugelmass

October 23, 2012

Presentation TCT 2012

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

Presenter: Paul Gurbel

October 23, 2012

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Presentation TCT 2012

TCT-28. Is the Rate of Femoral Access Site Complications Increased in the Hands of 'Radialists'?

Presenter: Stefano Rigattieri

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

Presenter: Andrej Schmidt

October 23, 2012

Presentation TCT 2012

TCT-47. Two-year Clinical Outcome of the TWENTE Trial, A Randomized Controlled Trial Comparing Second-generation Zotarolimus-eluting Resolute Stents vs. Everolimus-eluting...

Presenter: Clemens von Birgelen

October 23, 2012

Presentation TCT 2012

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Presenter: Allan Schwartz

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Presentation TCT 2012

TCT-20. IVUS Predictors of Stent Thrombosis: Results from the Prospective, Multicenter ADAPT-DES Study

Presenter: Akiko Maehara

October 23, 2012

Advertisement

Slides

Pathogenesis of Vulnerable Plaque 2012: What's New?

Selection of Angioplasty Guiding Catheters, Wires, and Balloons

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

HFPEF: Overview of Pathophysiology and Therapies

TCT-28. Is the Rate of Femoral Access Site Complications Increased in the Hands of 'Radialists'?

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

TCT-47. Two-year Clinical Outcome of the TWENTE Trial, A Randomized Controlled Trial Comparing Second-generation Zotarolimus-eluting Resolute Stents vs. Everolimus-eluting...

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

TCT-20. IVUS Predictors of Stent Thrombosis: Results from the Prospective, Multicenter ADAPT-DES Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content